FindTrial
Sign In

"Iron status in moderate to late preterm babies"

â??Evaluation of iron status in moderate to late preterm infants receiving iron supplementationâ?? - a prospective study. - MLP Iron trial

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/03/018187
Enrollment
152
Registered
2019-03-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P073- Preterm [premature] newborn [other]

Interventions

None listed

Sponsors

Alok Kumar M K
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Inborn neonates with gestation age between 32 weeks to 36 weeks (moderate to late preterm).

Exclusion criteria

Exclusion criteria: 1. Blood transfusion within 6 weeks of birth 2. Babies who underwent exchange transfusion 3. Babies who underwent major surgery within 6 weeks of birth 4. Babies with twin to twin transfusion (monochorionic monoamniotic twins) 5. Sick babies who are not stable within 2 weeks of life

Design outcomes

Primary

MeasureTime frame
Proportion of Moderate to late preterm babies having ID/IE at 14-16 weeks age while on standard iron supplementation.Timepoint: 4 months—

Secondary

MeasureTime frame
Iron status and Development outcome.Timepoint: 1 year;Predictors of Iron deficiency and AnemiaTimepoint: 4 months;Proportion of MLP having abnormal General Movement Assessment at 14-16 weeks.Timepoint: 4 months;Proportion of MLP with growth parameters -2 Z score as per intergrowth charts.Timepoint: 4 months;Proportion of Moderate to late preterm babies with Iron deficiency anemia.Timepoint: 4 months—

Countries

India

Contacts

Public ContactDr Naveen Jain

Kerala institute of medical sciences

naveen_19572@hotmail.com9387814568

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026